CIZZLE BIOTECH LTD.
Cizzle Biotech Ltd. focuses on the development of CIZ1 gene and its potential as a diagnostic biomarker for the early detection and management of lung cancer.
CIZZLE BIOTECH LTD.
Industry:
Biotechnology Health Care
Founded:
2005-01-01
Address:
York, York, United Kingdom
Country:
United Kingdom
Website Url:
http://www.cizzlebiotechnology.co.uk
Total Employee:
11+
Status:
Active
Total Funding:
853.38 K USD
Technology used in webpage:
IPv6 1and1
Current Employees Featured
Founder
Investors List
Finance Yorkshire
Finance Yorkshire investment in Venture Round - Cizzle Biotech Ltd.
White Rose Technology Seedcorn Fund
White Rose Technology Seedcorn Fund investment in Venture Round - Cizzle Biotech Ltd.
Yorkshire Cancer Research
Yorkshire Cancer Research investment in Venture Round - Cizzle Biotech Ltd.
Viking Fund
Viking Fund investment in Venture Round - Cizzle Biotech Ltd.
Yorkshire Cancer Research
Yorkshire Cancer Research investment in Venture Round - Cizzle Biotech Ltd.
White Rose Technology Seedcorn Fund
White Rose Technology Seedcorn Fund investment in Venture Round - Cizzle Biotech Ltd.
White Rose Technology Seedcorn Fund
White Rose Technology Seedcorn Fund investment in Seed Round - Cizzle Biotech Ltd.
Official Site Inspections
http://www.cizzlebiotechnology.co.uk
- Host name: 217-160-0-129.elastic-ssl.ui-r.com
- IP address: 217.160.0.129
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
More informations about "Cizzle Biotech Ltd."
Cizzle Biotech
Cizzle Biotech is developing a solution for a cost effective and an earlier way to detect lung cancer and reduce the need for repeated CT scanning.See details»
Cizzle Biotechnology Holdings Plc - AnnualReports.com
Cizzle Biotechnology Holdings Plc engages in developing a blood test for the early detection of various forms of lung cancer. It develops CIZ1B protein gene and its potential as a diagnostic biomarker for detection and management of …See details»
Cizzle Biotech Ltd. - Crunchbase Company Profile
When was the last funding round for Cizzle Biotech Ltd.? Cizzle Biotech Ltd. closed its last funding round on Mar 12, 2012 from a Venture - Series Unknown round. Who are Cizzle Biotech Ltd. 's competitors? Alternatives and possible …See details»
Cizzle Biotechnology Holdings Plc (CIZ.L) - Yahoo Finance
See the company profile for Cizzle Biotechnology Holdings Plc (CIZ.L) including business summary, industry/sector information, number of employees, business summary, corporate …See details»
Cizzle Biotechnology Holdings Plc (LON: CIZ) Company Profile
Nov 15, 2024 Cizzle Biotechnology Holdings Plc, together with its subsidiaries, develops an immunoassay test for the CIZ1B cancer biomarker for the early detection of lung cancer in the …See details»
Cizzle Biotechnology plc - LinkedIn
Cizzle Biotechnology plc | 483 followers on LinkedIn. Cizzle is a UK based developer of a blood test for the early detection of a majority of different forms of lung cancer | Cizzle Biotechnology ...See details»
Announcements - Cizzle Biotech
Jun 30, 2024 IFC Advisory Birchin Court 20 Birchin Lane London EC3V 9DU +44 (0)20 3934 6630 [email protected]See details»
CIZZLE BIOTECHNOLOGY HOLDINGS PLC - London Stock Exchange
CIZZLE BIOTECHNOLOGY HOLDINGS PLC CIZ Company page - Search stock, chart, recent trades, company information, trading information, company news, fundamentals Discover Start …See details»
Cizzle Biotechnology Limited continues to develop
Sep 17, 2021 The University of York is to collaborate with diagnostics development specialists Cizzle Biotechnology to develop a blood test to detect lung cancer. Image courtesy of the National Cancer Institute via …See details»
Transforming Lung Cancer Detection - About Cizzle Bio, Inc.
Born from a partnership with Cizzle Biotechnology PLC, we utilize patented technologies that have set new standards in the early detection of lung cancer. Our research and development …See details»
Cizzle 2020 Annual Report and Notice of AGM[24]
Cizzle Biotechnology, a UK based developer of a blood test for the early detection of a majority of different forms of lung cancer, is pleased to announce the Company's Annual Report for the …See details»
Major Step Forward in Cizzle Biotechnology's Programme with Bio …
Sep 20, 2023 Dr. Allan Syms, Executive Chairman of Cizzle Biotechnology plc, discusses the completion of their Evaluation Programme with Bio-Techne for the CIZ1B cancer biomarker. …See details»
The Science Behind Cizzle Bio: CIZ1B Biomarker | Cizzle Bio, Inc.
At Cizzle Bio, Inc., we are dedicated to revolutionizing the early detection of lung cancer through the use of groundbreaking diagnostic tools developed by Cizzle Biotechnology PLC. Central to …See details»
Cizzle Biotechnology Holdings PLC, CIZ:LSE profile - FT.com
Nov 22, 2024 Cizzle Biotechnology Holdings Plc is a United Kingdom-based diagnostics development company. The Company is engaged in the development of a blood test for the …See details»
Cizzle and Bio-Techne Announce Completion of Evaluation
Sep 19, 2023 LONDON and MINNEAPOLIS, Sept. 19, 2023/ PRNewswire/-- Bio-Techne Corporation and Cizzle Biotechnology Holdings plc, the UK- based diagnostics developer, are …See details»
Publications - Cizzle Biotech
Dec 31, 2021 IFC Advisory Birchin Court 20 Birchin Lane London EC3V 9DU +44 (0)20 3934 6630 [email protected]See details»
Press Releases - Bio-Techne Corporation
Sep 19, 2023 LONDON and MINNEAPOLIS, Sept. 19, 2023 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) and Cizzle Biotechnology Holdings plc, the UK-based …See details»
News - Cizzle Biotech
Dec 31, 2023 Cizzle Biotechnology to take early lung cancer test to £3b China market (Interview) Go to article. Load More. Headquarters. 6th Floor 60 Gracechurch Street London …See details»
The Biomarker - Cizzle Biotech
There were more than 2 million new cases in 2018. The majority of lung malignancies have already spread by the time they are diagnosed. CT scanning currently has a false positive rate …See details»